Hepatitis C virus and allogeneic stem cell transplantation still matters!

Haematologica

Volumn 94, Issue 2, 2009, Pages 170-172

  Socié, Gérard ^a   De Latour, Régis Peffault ^a   McDonald, George B ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; ERYTHROPOIETIN; RIBAVIRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLOGENEIC STEM CELL TRANSPLANTATION; ANEMIA; BILIRUBIN BLOOD LEVEL; CANCER PATIENT; CANCER SURVIVAL; CASE CONTROL STUDY; EDITORIAL; FOLLOW UP; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMATOLOGIC MALIGNANCY; HEPATITIS C VIRUS; HIGH RISK PATIENT; HUMAN; INFECTION PREVENTION; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FUNCTION TEST; OVERALL SURVIVAL; RECURRENT CANCER; SURVIVAL TIME; SURVIVOR; THERAPY EFFECT; THROMBOCYTOPENIA;

ANTINEOPLASTIC AGENTS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER DISEASES; VIRUS ACTIVATION;

EID: 59449100795     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.2008.002048     Document Type: Editorial

References (21)

1. Socié G, Stone JV, Wingard JR, Weisdorf D, Henslee-Downey PJ, Bredeson C, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry. N Engl J Med 1999;341:14-21.
2. Peffault de Latour R, Ribaud P, Robin M, Valla D, Marcellin P, Socié G, et al. Allogeneic hematopoietic cell transplant in HCV-infected patients. J Hepatol 2008;48:1008-17.
3. Strasser SI MG. Gastrointestinal and Hepatic complications. In: Blume KG FS, Appelbaum FR, editor. Thomas' Hematopoietic cell Transplantation 4th Edition. Oxford: Blackwell Science Ltd; in press.
4. Strasser SI, Sullivan KM, Myerson D, Spurgeon CL, Storer B, Schoch HG, et al. Cirrhosis of the liver in long-term marrow transplant survivors. Blood 1999;93:3259-66.
5. Peffault de Latour R, Levy V, Asselah T, Marcellin P, Scieux C, Ades L, et al. Long-term outcome of hepatitis C infection after bone marrow transplantation. Blood 2004;103:1618-24.
6. Strasser SI, Myerson D, Spurgeon CL, Sullivan KM, Storer B, Schoch HG, et al. Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up. Hepatology 1999;29:1893-9.
7. Hogan WJ, Maris M, Storer B, Sandmaier BM, Maloney DG, Schoch HG, et al. Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. Blood 2004;103:78-84.
8. Ljungman P, Johansson N, Aschan J, Glaumann H, Lonnqvist B, Ringden O, et al. Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients. Blood 1995;86:1614-8.
9. Maruta A, Kanamori H, Fukawa H, Harano H, Matsuzaki M, Miyashita H, et al. Liver function tests of recipients with hepatitis C virus infection after bone marrow transplantation. Bone Marrow Transplant 1994;13:417-22.
10. Locasciulli A, Bacigalupo A, VanLint MT, Cavalletto D, Pontisso P, Testa M, et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995;16:407-11.
11. Shulman HM, Sharma P, Amos D, Fenster LF, McDonald GB. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology 1988;8:463-70.
12. Kaji K, Nakanuma Y, Sasaki M, Unoura M, Kobayashi K, Nonomura A, et al. Hepatitic bile duct injuries in chronic hepatitis C: histopathologic and immunohistochemical studies. Mod Pathol 1994;7:937-45.
13. Strasser SI, Shulman HM, Flowers ME, Reddy R, Margolis DA, Prumbaum M, et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000;32:1265-71.
14. Ramos CA, Saliba RM, de Pádua L, Khorshid O, Shpall EJ, Giralt S, et al. Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematological malignancies. Haematologica 2009; 94:249-57.
15. Locasciulli A, Bacigalupo A, Vanlint MT, Tagger A, Uderzo C, Portmann B, et al. Hepatitis C virus infection in patients undergoing allogeneic bone marrow transplantation. Transplantation 1991;52:315-8.
16. Norol F, Roche B, Girardin MF, Kuentz M, Desforges L, Cordonnier C, et al. Hepatitis C virus infection and allogeneic bone marrow transplantation. Transplantation 1994; 57:393-7.
17. Tomas JF, Pinilla I, Garcia-Buey ML, Garcia A, Figuera A, Gomez-Garcia de Soria VGG, et al. Long-term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 2000;26:649-55.
18. Ivantes CA, Amarante H, Ioshii SO, Pasquini R. Hepatitis C virus in long-term bone marrow transplant survivors. Bone Marrow Transplant 2004;33:1181-5.
19. Ljungman P, Andersson J, Aschan J, Bjorkstrand B, Hagglund H, Lonnqvist B, et al. Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation. Clin Infect Dis 1996;23:167-9.
20. Giardini C, Galimberti M, Lucarelli G, Polchi P, Angelucci E, Baronciani D, et al. Alpha-interferon treatment of chronic hepatitis C after bone marrow transplantation for homozygous beta-thalassemia. Bone Marrow Transplant 1997;20: 767-72.
21. Peffault de Latour R, Asselah T, Levy V, Scieux C, Devergie A, Ribaud P, et al. Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients. Bone Marrow Transplant 2005;36:709-13.